Quality assessment and transfusion efficacy of buffy coat-derived platelet concentrates washed with platelet additive solution

被引:6
|
作者
Fernandez-Munoz, Hermogenes [1 ,2 ]
Castilla-Llorente, Cristina [1 ,3 ]
Plaza, Eva M. [1 ]
Martinez-Millan, Cristina [1 ]
Heras, Inmaculada [1 ]
Iniesta, Pastora [1 ]
Amigo, Maria L. [1 ]
Ferrer-Marin, Francisca [1 ]
Candela, Maria J. [1 ]
Lozano, Maria L. [1 ]
Vicente, Vicente [1 ]
Rivera, Jose [1 ]
机构
[1] Univ Murcia, Morales Meseguer Univ Hosp, Reg Blood Donat Ctr, Haematol & Med Oncol Serv,IMIB Arrixaca,CIBERER, Murcia, Spain
[2] Rafael Mendez Univ Hosp, Haematol & Blood Therapy Serv, Lorca, Spain
[3] Gustave Roussy Inst, Haematol Serv, Villejuif, France
关键词
washed platelet concentrates; washed platelet function; washed platelet transfusion; VerifyNow (R) system; IN-VITRO QUALITY; WASHING PLATELETS; STORAGE; SYSTEM; REFRACTORINESS; APHERESIS; REMOVAL;
D O I
10.2450/2017.0277-16
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Transfusion of washed platelet concentrates (W-PC) is recommended for some patients, such as those who have had previous severe allergic transfusion reactions. However, we still lack a standardised method for preparing these products. Here, we assessed the effect of a manual washing procedure on in vitro platelet quality and on the transfusion efficacy of W-PCs. Materials and methods. Buffy coat-derived W-PC in Composol solution were prepared by one-step centrifugation. Platelet activation and function were evaluated before and after washing by means of: (i) CD62 expression by flow cytometry; (ii) platelet aggregation (LTA); and (iii) the VerifyNow (R) P2Y12 test. A pilot prospective transfusion study was carried out in 11 onco-hematology patients receiving, in a short time, two consecutive transfusions: one with standard PC (S-PC) and one with W-PC. The post-transfusion platelet increment, the 1 h and 24 h corrected count increment (CCI) and occurrence of bleeding events were used as indices of transfusion efficacy. Results. Platelet recovery in W-PC was 84.8 +/- 5.4%. Washing slightly increased platelet activation in W-PC vs pre-washed samples (% CD62+ platelets 23.6 +/- 7 vs 14.8 +/- 1; p=0.03). As compared to prewash samples, platelet reactivity of W-PC as measured by VerifyNow (R) P2Y12 was significantly lower with ADP (PRU 32.2 +/- 37.7 vs 4.2 +/- 2.4, p=0.027), but similar using TRAP. Platelet aggregation responses to TRAP, collagen, ristocetin and arachidonic acid were maintained in W-PC. The pilot transfusion trial showed similar 1 h (13.5 +/- 5.6 vs 11.5 +/- 7.3, p=0.49) and 24 h (11 +/- 7.2 vs 9 +/- 6.5, p=0.48) CCI for S-PC and W-PC. Transfusion of W-PC was not associated with an increased number of bleeding events. Discussion. We have set up a simple method to obtain buffy-coat-derived W-PC, which has minor effects on in vitro platelet quality and transfusion effectiveness. This procedure can be easily implemented in transfusion centres for on-demand preparation of washed platelets.
引用
收藏
页码:273 / 278
页数:6
相关论文
共 50 条
  • [41] Quality of the platelet concentrates derived from atreus buffy coats
    Sward-Nilsson, A. M.
    Jeansson, M.
    Gintse, E.
    Callaert, M.
    [J]. VOX SANGUINIS, 2006, 91 : 308 - 309
  • [42] PRELIMINARY EVALUATION OF A NOVEL AUTOMATED DEVICE FOR BUFFY -COAT DERIVED PLATELET CONCENTRATES
    Santos, M.
    de la Sota Javier, F.
    Venturini, P.
    Ferreira, F.
    Silva, S.
    Castro, L.
    [J]. VOX SANGUINIS, 2010, 99 : 203 - 204
  • [43] In Vitro Quality of Platelet Concentrates Produced with the TACSI from 4 Buffy Coats and Subsequent Storage in Platelet Additive Solution
    Johnson, L. N.
    Winter, K. M.
    Reid, S.
    Hartkopf-Theis, T.
    Kwok, M.
    Marks, D. C.
    [J]. TRANSFUSION, 2011, 51 : 59A - 59A
  • [44] Soluble CD40L and CD62P levels differ in single-donor apheresis platelet concentrates and buffy coat-derived pooled platelet concentrates
    Sut, Caroline
    Tariket, Sofiane
    Aloui, Chaker
    Arthaud, Charles-Antoine
    Eyraud, Marie-Ange
    Fagan, Jocelyne
    Chavarin, Patricia
    Hamzeh-Cognasse, Hind
    Laradi, Sandrine
    Garraud, Olivier
    Cognasse, Fabrice
    [J]. TRANSFUSION, 2019, 59 (01) : 16 - 20
  • [45] The history of buffy coat platelet concentrates: The Dutch story
    van der Meer, Pieter F.
    Reesink, Hendrik W.
    de Korte, Dirk
    Loos, Johannes A.
    Klei, Thomas R. L.
    [J]. VOX SANGUINIS, 2022, 117 (07) : 913 - 919
  • [46] Comparison of two automated blood fractionation systems in the routine preparation of leucoreduced pooled buffy coat derived platelet concentrates in additive solution
    Lozano, M
    Mazzara, R
    Ordinas, A
    [J]. TRANSFUSION, 2004, 44 (09) : 67A - 67A
  • [47] The platelet proteasome and immunoproteasome are stable in buffy-coat derived platelet concentrates for up to 7 days
    Colberg, Lisa
    Cammann, Clemens
    Wesche, Jan
    Topfstedt, Eylin
    Seifert, Ulrike
    Greinacher, Andreas
    [J]. TRANSFUSION, 2021, 61 (09) : 2746 - 2755
  • [48] Comparative analysis of the quality of platelet concentrates produced by apheresis procedures, platelet rich plasma, and buffy coat
    Li, Meng
    Zhao, Yuwei
    Chen, Xue
    Du, Xinman
    Luo, Yue
    Li, Ying
    Kang, Jianxun
    Wan, Like
    Tang, Jingyun
    Fu, Xuemei
    [J]. TRANSFUSION, 2024, 64 (02) : 367 - 379
  • [49] Novel system for storage of buffy-coat-derived platelet concentrates in a glucose-based platelet additive solution: parameters and metabolism during storage and comparison to plasma
    Gyongyossy-Issa, M. I. C.
    Zhang, J. G.
    Culibrk, B.
    Hunter, F.
    Levin, E.
    Scammell, K.
    Weiss, S.
    Holmes, D. L.
    Holme, S.
    [J]. VOX SANGUINIS, 2009, 97 (02) : 102 - 109
  • [50] Platelet transfusion reactions do not occur more often in recipients transfused with apheresis versus buffy coat platelet concentrates
    Cserti-Gazdewich, Christine
    Escorcia, Alioska
    Pendergrast, Jacob
    Lieberman, Lani
    Skeate, Robert
    Lin, Yulia
    Callum, Jeannie
    [J]. TRANSFUSION, 2016, 56 (12) : 3144 - 3147